key: cord-0804269-seccqc7y authors: Brooks, Samantha K.; Weston, Dale; Greenberg, Neil title: Social and psychological impact of the COVID-19 pandemic on people with Parkinson’s disease: Scoping review date: 2021-09-01 journal: Public Health DOI: 10.1016/j.puhe.2021.08.014 sha: f9d62e377c212eff2a58c79ad148fa8c9d20e3d8 doc_id: 804269 cord_uid: seccqc7y Objectives The COVID-19 pandemic caused countries across the globe to impose restrictions to slow the spread of the virus, with people instructed to stay at home and reduce contact with others. This reduction in social contact has the potential to negatively impact on mental health and wellbeing. The restrictions are particularly concerning for people with existing chronic illnesses such as Parkinson’s disease, who may be especially affected by concerns about the pandemic and associated reduction of social contact. The aim of this review was to synthesise published literature on the impact of the COVID-19 pandemic on the social and psychological wellbeing of people with Parkinson’s disease. Study design Scoping review. Methods We searched five electronic databases for English-language articles containing primary data on this topic. Results Thirty-one relevant studies were found and included in the review. Six main themes were identified: impact of the pandemic on physical and mental health; COVID-19 concerns; access to healthcare; impact on daily and social activities; impact on physical activity; and impact on caregivers. Levels of perceived risk of COVID-19 differed across studies, but the majority of participants had adopted preventive measures such as staying at home and reducing social contacts. Participants in many studies reported a discontinuation of regular healthcare appointments and physiotherapy as well as concerns about being able to obtain medication. Loss of daily activities and social support were noted by many participants. There was mixed evidence on the impact of the pandemic on physical exercise, with some studies finding no change in physical activity and others reporting a reduction; generally, participants with reduced physical activity had poorer mental health and greater worsening of symptoms. Caregivers of people with Parkinson’s were more likely to be negatively affected by the pandemic if they cared for people with complex needs such as additional mental health problems. Conclusions The COVID-19 pandemic has had negative effects on the physical and mental health of people with Parkinson’s disease, perhaps due to disruption of healthcare services, loss of usual activities and supports, and reduction in physical activity. We make recommendations for policy, practice and future research. December 2019 saw the outbreak of novel coronavirus COVID-19, which has (as of April 2021) affected almost every country and seen over 150,000,000 confirmed cases and 3,000,000 deaths. 1 Most countries imposed restrictions on movement and social activities to slow the spread of the virus, leading to concerns that social isolation could negatively impact on wellbeing and mental health. 2 These social restrictions, and potential loss of access to usual support systems, may have particularly affected people with existing chronic health conditions, such as people with Parkinson's disease 3 (PwPD) -a neurodegenerative disease marked by cognitive impairment, frailty and comorbidity. The effects of COVID-19 restrictions could be extremely detrimental to PwPD in several ways, with consequences to structural healthcare, physical health and mental health. PwPD have been labelled vulnerable due to pandemic-related disruptions in specific treatments 4 such as deep brain stimulation. 5 In a global survey of healthcare workers, many reported their PD patients had experienced difficulty obtaining regular medications and increased disability. 6 The pandemic has also caused disruption to PD-related research and clinical trials. 7 The potential loneliness caused by restrictions on socialisation and lack of access to usual support may pose particular risks for PwPD, who are at risk of depression when socially isolated. 8 Previous research has shown that participation in social activities is associated with better quality of life and better mental health for PwPD. 9 Evidence suggests that PwPD who feel lonely or isolated have greater symptom severity and poorer quality of life 10 whilst social contact is protective of both psychological wellbeing and cognitive performance 11 therefore the pandemic-related restrictions on socialisations may have had a negative impact. Helmlich and Bloem 3 raised concerns about the mental health impact of the pandemic on PwPD. They suggest the drastic changes and restrictions imposed require flexibility and rapid adaptation to new circumstances, which may be difficult for PwPD, many of whom experience cognitive and motor inflexibility; PwPD are already at increased risk of chronic stress; and a reduction in physical activities may greatly affect PwPD, for whom exercise has been associated with better clinical outcomes and less psychological stress. Mental health problems are already common in PwPD, including depression, 12 anxiety 13 and obsessive-compulsive disorder; 14 there is a risk these could worsen due to the pandemic. It is therefore important to understand the specific impact of the COVID-19 pandemic on PwPD in order to know how best to support them at this time, and also in the case of future pandemics. This scoping review aimed to synthesise existing literature on the impact the COVID-19 pandemic has had on the social and psychological wellbeing of PwPD and their experiences during the pandemic-related restrictions. We did not aim to investigate the impact on PwPD of actually contracting COVID-19; rather, we aimed to collate literature on how the social restrictions imposed due to COVID-19 may have affected their wellbeing. What has been the impact of the COVID-19 pandemic and associated social restrictions on the social and psychological wellbeing of PwPD? In April 2021, we systematically searched PsycInfo, Medline, Embase, Global Health and Web of Science using the following search strategy: (coronavirus or covid* or sars-cov-2) AND (parkinson*) AND (psychological or mental health or wellbeing or well-being or depression or anxiety or emotion* or stress* or distress* or psychiatric or resilience or mood*). Reference lists of relevant studies were hand-searched. Inclusion criteria were: studies had to be published in the English language; contain primary data on the impact the COVID-19 pandemic has had on PwPD; and be published in journals (i.e. preprints were excluded). Case studies were excluded but studies with any sample size greater than one were included. There were no exclusion criteria relating to study methodology. Citations were imported into EndNote reference management software where duplicates were automatically removed. The titles and abstracts were screened for relevancy, and any clearly not relevant to the review were excluded. Full texts of remaining citations were obtained and screened against the inclusion criteria. Any not meeting the criteria at this stage were excluded. Data from included studies was extracted onto a spreadsheet with the following headings: Authors, year of publication, country, time-point of data collection, number of participants, demographic characteristics of participants, variables measure, tools used, and key results. Thematic analysis 16 was used to group the results of included studies into a typology. Each of the themes identified is summarised in the results section below with a narrative description of the evidence found within each theme. Database searches yielded 159 results, of which 42 were duplicates, and an additional nine papers were found via hand-searching reference lists. After screening, a total of 31 studies remained for inclusion in the review. Figure I illustrates the screening process. The studies included in the review were from a range of countries: Italy, 17, 18, 19, 20, 21, 22, 23, 24, 25 China, 26, 27 India, 28, 29 Japan, 30, 31 Turkey, 32,33 the USA, 34, 35 Egypt, 36 Germany, 37 Iran, 38 Luxembourg, 39 Morocco, 40 the Netherlands, 41 Slovenia, 42 South Korea, 43 Spain, 44 and the UK; 45 one study included participants from both Denmark and Sweden 46 and another included participants from every continent. 47 Study populations ranged from 28-6,881 participants. Various methodologies were used: the majority of studies were cross-sectional and used quantitative measures; 19,21,23,25,28,29,30,31,32,33,34,36,38,41,42,43,44,47 two used qualitative interviews; 37, 39 and two used a combination of qualitative and quantitative measures. 17, 20 Two studies included quantitative measures at multiple timepoints during the COVID-19 pandemic, 26, 40 two studies asked participants to retrospectively rate aspects of their pre-pandemic wellbeing as well as their current status, 27, 35 and four compared measures taken during lockdown to assessments already completed pre-pandemic. 18, 22, 45, 46 One study was a descriptive analysis of emails, texts and voice messages from PwPD to their clinic. 24 Table I presents an overview of study details, and Supplementary File I presents an overview of their key results. Thematic analysis revealed six main themes: impact of the pandemic on physical and mental health; COVID-19 concerns; access to healthcare; impact on daily and social activities; impact on physical activity; and impact on caregivers. J o u r n a l P r e -p r o o f 18 In other studies, symptom worsening was not associated with age, age at onset of PD, gender, or disease duration 25 or experiencing symptoms of COVID-19. 23 One study 46 found that some aspects of health-related quality of life of PwPD improved during the pandemic such as sleep, concentration and being able to get around in public places. Participants indicated this was due to not having usual social pressures, enjoying life being simple and slow, and enjoying being at home. Other studies found no significant worsening of mental health problems 22, 40 or only a minority of participants reporting worsening mental health symptoms. 19, 29 Worsening of mental health symptoms was often attributed by participants to the pandemic. 36 Perceived COVID-19 risk differed across studies: in some, the vast majority of participants saw COVID-19 as dangerous 33, 37 and were more likely to view the pandemic as a threat than healthy controls 37 because they saw themselves as being particularly at risk of infection. 34, 37 Other studies reported lower perception of risk. 29 In some studies, most participants experienced this disruption 23, 25 while others reported only a minority did. 29, 31 Only one study 18 found no reported treatment changes at all. Loss of access to healthcare was reported to be a source of stress by participants 37 and was significantly associated with worsening motor and psychiatric symptoms. 23, 47 Concerns about drug availability were associated with anxiety 38 and difficulties in daily living. 36 One study 47 found that disruption to care was more likely in those with longer (9+ years) duration of PD, non-white participants, and participants of lower income; additionally, people of Latinx ethnicity reported greater difficulty obtaining medication. Participants in many studies reported loss of daily activities, including outdoor activities, social activities, and obtaining food, 17, 23, 26, 34, 37, 41, 43, 47 which were significantly associated with worsening psychiatric symptoms. 23 Patients who experienced interruptions to social activities or were asked to self-isolate were more likely to report worsening of PD symptoms. 47 reported needing increased support to cope with the consequences of the pandemic. 39 Lack of support J o u r n a l P r e -p r o o f appeared to be associated with poor wellbeing. 40, 41 PwPD felt particularly stressed by lack of contact with grandchildren 37 as well as being restricted in visiting loved ones in hospital or not being able to attend the funeral of a loved one. 41 Some studies found no change in physical activity 25, 28 or a small minority reporting loss of physical activities. 29 In Templeton et al.'s 35 study, PwPD reported minimal change in the number of active days per week but a notable decrease in number of active minutes per day and number of total activities due to restrictions. Other studies found that between a quarter 44 and almost three quarters 36 of participants reported a reduction in amount, duration or frequency of physical activity. One study found physical activity during the pandemic was low for both patients and controls 32 whilst another found that PwPD had significantly less physical activity than controls. 36 Reduced activity was attributed to both closing of sports facilities and concerns about contracting COVID-19 when going out for exercise. 43 Participants were concerned about the consequences of reduced physical activity. 39 Not being able to perform usual physical activities was reported by PwPD to have a negative effect on wellbeing 41 and PwPD who experienced interruptions to exercise were more likely to report worsening of PD symptoms. 25, 41, 43, 47 PwPD practising daily physical activity had significantly lower anxiety and depression scores than those who were inactive. 21 A small number of studies also considered the impact of the pandemic on caregivers of PwPD. One study found that caregivers reported less severe anxiety than PwPD, but significantly higher anxiety than controls; 38 others found no difference in the proportion of PwPD and caregivers with worsened depression or anxiety 30, 31 and another found that stress during home confinement increased more for caregivers than PwPD. 21 This review is the first to synthesise data on the burden of the COVID-19 pandemic on PwPD. Overall, the data suggests that due to the pandemic and associated restrictions many have experienced Worsening of motor symptoms is often associated with worsening psychological symptoms; it is unclear from the data if these occur simultaneously or if one happens first and impacts on the other. What is clear is that during the COVID-19 pandemic and indeed any future pandemics, it is important that PwPD do not lose access to their medical care. Additionally, loss of daily activities, social support, or physical activity could impact on mental health and lead to worsening of symptoms so it is important that PwPD maintain these as much as they can. Some studies in our review found that PwPD had changed their behaviours to stay at home and avoid face-to-face contact entirely, despite PwPD not being instructed to 'shield'this could come at a cost to their mental health, as evidence suggests that older adults who self-isolate during the pandemic experience higher levels of depression, anxiety and loneliness. 49 Telemedicine may be a promising avenue for consideration to ensuring continuity of care, representing a potential solution to the difficulties in accessing regular health care and physiotherapy reported by participants across studies. Preliminary studies suggest PwPD are open to the idea of telemedicine but may be less inclined if they are not used to using technology such as smartphones. 50 Given the importance of physical exercise, telehealth to encourage appropriate physical activity, such as telerehabilitation and apps encouraging patient-initiated exercises, could be helpful. 51, 52 Healthcare professionals and caregivers should promote home-based exercises for PwPD during the pandemic; these have previously been found to improve quality of life for PwPD 53 and would be particularly beneficial during the pandemic. Doing home-based exercises remotely with a group (e.g. online or via video calls) could increase sense of socialisation in addition to providing the usual benefits of physical activity. 54 The importance of social networks and connectedness has been well-documented 55, 56 and previous research highlights the importance of this for the mental health of PwPD 57 but the restrictions of the pandemic may lead to people feeling socially isolated. It is important that PwPD maintain informal support networks during the pandemic, for example by communicating virtually with friends and family. It may also be helpful for PwPD to join virtual support groups as a way of developing relationships with others with the same condition and sharing experiences, advice or encouragement. Support groups have previously been shown to be associated with better mental health and quality of life in PwPD. 8 To minimise pandemic-related concerns, it is important for PwPD to receive appropriate, timely information not only about COVID- 19 itself, but about their medical care during the pandemic and J o u r n a l P r e -p r o o f any changes to usual services. 24 It would also be useful for PwPD to receive information about selfcare during the pandemic, with advice for staying active, reminders about keeping in contact with friends, suggestions for keeping occupied and cognitively engaged, and tips for coping effectively during a stressful time. This could be in the form of leaflets or information on healthcare providers' websites. Thus far, one paper has been published on a potential intervention to support PwPD during the pandemic; 58 an outreach programme involving a nurse and licensed clinical social worker proactively calling vulnerable or high-risk patients to carry out a needs assessment and provide appropriate resources or referrals tailored to each individual, such as safety tips, exercise videos, relaxation resources, and contact information for support helplines. Although no formal evaluation of the programme has been published, the authors report that initial feedback from PwPD and caregivers has been extremely positive. However, formal evaluation is required before any firm supportive recommendation could be made. It is important for further studies to examine the impact of the COVID-19 pandemic on PwPD, particularly in countries who experienced further waves of the virus and consequently extended lockdowns and social restrictions. More research on the effectiveness of telehealth for the management of PD, as well as how to ensure all PwPD have access to telehealth and can be encouraged to use it, is also necessary. It may be helpful to further investigate potential sociodemographic predictors of symptom worsening and poor mental health in PwPD during the pandemic. It was concerning that one study suggested differences in ethnicity and income in terms of access to health care; this needs to be investigated further to establish what inequalities exist and how these can be reduced. The included studies were carried out near the beginning of the pandemic when restriction periods were relatively short. The impact of the pandemic may be felt more severely by PwPD now that the pandemic has been going on for more than a year and restrictions are still in place in many countries. It would be useful to update this review in the future when more longitudinal studies have been published. Although a wide variety of countries were represented by the studies reviewed, it is possible that the decision to limit to English-language papers may mean that important studies were missed. Relevant papers could potentially have been missed due to the search terms we used and the decision to limit the searches to five databases; future reviews may consider searching a wider variety of databases, including grey literature, and using a wider variety of search terms. Although the search was limited to articles published in journals, and all had presumably been subject to Editor review, a minority of the included papers were published as rapid communications which appear to have been published within days of submission and we acknowledge that these may not have undergone a rigorous peer review process. Only one author screened papers and extracted data. Ideally, a second reviewer would carry out their own independent screening to ensure all relevant papers are included. The social restrictions many countries have put in place have led to many challenges for PwPD such as loss of usual daily activities, social contact, physical exercise and healthcare, as well as new or worsening Parkinson's symptoms. Additionally, caregivers appear to be under increased strain particularly caregivers of PwPD with complex needs. While some positive effects of the pandemic have been notedsuch as enjoyment of life being quieter and slowerthese appear to be a minority. This review suggests a number of potential ways of supporting PwPD during the pandemic including telemedicine to ensure access to healthcare is maintained, ensuring PwPD maintain contact with friends and family virtually, encouraging PwPD to do home-based exercises, virtual support groups, and advice on self-care and effective coping strategies. We suggest further work is needed to identify which of these interventions is most promising and to develop more. Balci et al. 32 Patients' disease-related symptoms were worsened during lockdownworsening of motor and nonmotor symptoms reported by 68.9%; the symptom that most frequently worsened was bradykinesia; physical activity was low for both groups (no significant difference); no participants had anxiety or depression Baschi et al. (2020) 17 Number of instrumental activities of daily living (IADL) lost after quarantine were significantly higher in PwPD and mild cognitive impairment; based on caregivers' reports there were no significant differences between groups in worsening of cognition, worsening of preexistent NPS or disease acceleration, but ANOVA revealed that PwPD and mild cognitive impairment showed a significantly higher new onset of neuropsychiatric symptoms (NPS) than those with no cognitive impairment; this group (PD-MCI) also showed significantly greater worsening of motor symptoms and increased strain on caregivers than both other groups; number of IADL lost after quarantine was positively associated with PD-MCI; diagnosis of PD was positively associated with worsening of motor symptoms and increased caregiver strain in multivariate analysis in comparison to those without PD; PD-MCI patients showed higher frequencies than PD without MCI in all NPI symptoms except appetite/eating disturbances, but a significant trend was found only for depression, euphoria and aberrant motor behaviour; PD-MCI had significantly greater nighttime behaviours than those with MCI and no PD; PD-MCI showed significantly higher cognitive impairment and fatigue than PD with no MCI and borderline significant differences for depressed mood and sleep problems; in a comparison to those without PD, PD-MCI had significantly greater sleep problems, pain, urinary problems, constipation and fatigue with borderline significant differences for depressed mood, daytime sleepiness, and light-headedness on standing. Brown et al. (2020) 47 Healthcare was altered due to the pandemic in 62% of all respondents including cancelled appointments, reduced in-home care and difficulty obtaining medications; among patients, disruption to medical care was more likely in those with longer (more than 9 years) duration of illness, non-white participants, and lower income participants; more people of Latinx ethnicity reported difficulty obtaining medication; 39% of patients reported telemedicine appointments but those with lower household income were significantly less likely to attend telemedicine appointments; 35% of patients reported that at least one essential daily activity was disrupted; essential daily activities were more often disrupted in patients who lived alone, including getting food and getting regular homecare/housekeeping; other behaviours disrupted included cancelled exercise and social activities; many found alternative means of exercising such as online classes but this was significantly less likely for older patients; 51/5249 had symptoms of COVID-19/probable COVID-19 whilst 26 controls had COVID-19 symptoms; among patients who did not have COVID-19, new Parkinson's symptoms emerged and existing symptoms worsened in all domains (motor, mood, cognitive, sleep and autonomic); patients who experienced interruptions to medical care were significantly more likely to experience new or worsening symptoms in all domains, particularly motor symptoms; patients who experienced interruptions to exercise, social activities or were asked to self-isolate were more likely to report worsening of symptoms; women without COVID were more likely to report new or worsening motor, mood, sleep and autonomic problems whilst women with COVID were more likely to report new or worsening cognitive symptoms. De Micco et al. (2021) 18 Patients did not report need for treatment changes or psychiatric consultation as a result of lockdown; lower age at diagnosis and lower age at last assessment associated with greater avoidance; being female associated with greater avoidance and intrusion; higher disease severity associated with greater avoidance, hyperarousal and intrusion; higher lockdown hours per day associated with greater intrusion; avoidance, intrusion and hyperarousal all associated with higher pre-lockdown disease severity, apathy, anxiety, depression, fatigue, and poor quality of life; higher psychological distress during lockdown associated with being female, longer disease duration and time since last visit as well as prelockdown greater disease severity, apathy, anxiety, depression, sleepiness, fatigue and poorer quality of life; higher caregiver strain associated with greater disease severity, depression, fatigue, poorer quality of life and greater impact of Parkinson's on ability to cope with daily life; regression analysis confirmed the following associations: avoidance with disease severity and anxiety, hyperarousal with disease severity and anxiety, intrusion with disease severity and anxiety and number of lockdown hours per day, psychological distress with disease severity and anxiety and quality of life, and caregiver strain with impact of Parkinson's on ability to cope with daily life and the attention/memory aspect of the disease Del Prete et al. (2021) 19 Explored effects of lockdown in the non-Covid patients: 70% did not experience worsening of Parkinson's symptoms; 74.9% did not experience worsening of mood; 74.6% did not experience worsening of anxiety; 77.4% did not experience worsening of insomnia; 0.9% of whole sample had been diagnosed with COVID-19 El Otmani et al. (2021) 40 At the first evaluation 28% had depression and 32% had anxiety; after 6 weeks, 34% had depression and 30% had anxietyno significant difference; no effect of age, gender or disease severity on depression or anxiety; 4 of 6 patients who received deep brain stimulation had worsened; for patients who felt better after confinement, 40% suggested this was due to the presence of relatives; for patients who deteriorated, 33.3% were affected by reduced physical activities and 14% by lack of family support Feeney et al. 34 More than 85% felt their personal life had changed during the pandemic; the most common concerns were becoming infected, being at increased risk of infection due to Parkinson's disease, and requiring intensive hospital care due to infection; patients took various precautions such as cancelling personal and social activities and doctor's appointments, avoiding public spaces, stocking up on medications, praying, and wearing a face covering; 59.9% cancelled a doctor appointment; 55% were provided with telehealth or virtual medical appointment options; 38.2% had a telehealth visit instead of the cancelled appointment; 45.9% noticed negative change in Parkinson's symptoms; 64.6% reported no change in relationships with other household members; 74.4% reported no change in frequency of communication with others; most common sources of social support were others in the household and phone/video chats with friends and family; 63.5% had used a telehealth service and 46% of these would prefer to keep using telehealth after the pandemic; predictors of wanting to keep using telehealth were having used telehealth before the pandemic, receiving support/instructions for telehealth and having a carer to help them with the telehealth visit; 44.7% reported reduced hours of exercise; 72.9% reported reduced activities outside the home; 66.5% experienced nervousness or anxiety; 50.9% reported feeling down or depressed; 53.7% reported reduced interest or pleasure in doing things; 66.2% reported sleep disturbances; anxiety was associated with female gender, white ethnicity, and reduced exercise and inversely associated with having an annual household income over $100,000 and being retired; uncontrollable worry, depression or hopelessness, and isolation were associated with being female, annual household income of less than $50,000, and reduced exercise; sleep disturbance was associated with being female and Levodopa use; anxiety was most often attributed to fear of getting infected and uncertainty of when the pandemic would end; depression was most often attributed to inability to see or have physical contact with family or friends and having a history of depression; loss of interest was most often attributed to not leaving the house, apathy prior to COVID-19 and hopelessness or negative feelings about the future; sleep disturbances were most often attributed to prior sleep disturbances or COVID-related worry Guo et al. (2020) 26 Quality of life appeared significantly affected during the period of epidemic prevention and control: mobility, daily living activities, emotional wellbeing, stigma, cognition, communication, bodily discomfort, and total PDQ-39 scored were all significantly higher during prevention/control than after; no significant difference in social support during and after prevention/control; for patients who could easily get doctor's guidance, only mobility, activities of daily living, emotional wellbeing and total PDQ-39 scores were significantly higher during than after prevention/control; for those with difficulties contacting doctors, all domains except social support were significantly higher during than after prevention/control; all domains except social support showed significant differences during/after for patients who had changed routine medication during the pandemic. Hanff et al. (2020) 39 Emotional distress was a consequence of the pandemic, caused by fear of the virus, physical distancing and restricted communication with usual contacts, death or illness of family members and non-adherence to hygiene recommendations by health care professionals; alternative ways to continue hobbies and shopping need to be explored; participants had questions about the vulnerability of PwPD, interaction of PD-therapy with COVID-19, availability of medication and consequences of reduced physical activity; unmet needs of physiotherapy, rescheduled neurology appointments and medication; participants frequently relied on family members, cleaning staff, neighbours or nursing services/nursing homes for support and to meet unmet needs; increased support was needed to cope with the consequences of the pandemic (i.e. emotional distress and need to adapt daily and health-related activities) Janiri et al. (2020) 20 75.4% reported lifetime psychiatric symptoms; among these 22.8% presented with worsening of symptoms during the pandemic; of those with worsening symptoms the most frequent symptoms were depression (82.6%) and insomnia (52.2%); those reporting symptom exacerbation were more likely to be female and younger than those reporting symptom stability; worsening of symptoms was also associated with subjective worsening of neurological symptoms, pre-existing irritability and delusions, receiving antipsychotics, and not having received mood stabilisers; in a multivariate regression analysis, worsening psychological symptoms were predicted by worsening neurological symptoms, preexisting irritability, younger age and female gender. Kapel et al. (2021) 42 The impact of absent interventions was on motor function in 73.8% of patients; 61.9% had mental state impairments such as depression and anxiety; 21.4% had 1-3 days of existential crisis; 90.4% reported deterioration of motor function; 55.6% noted an increase in falls; 40.4% experienced loss of motivation; 80.9% experienced loss of motor function; 56.3% reported increased sleeping problems; 50% reported increased behaviour disorders. Kitani-Morii et al. 30 Patients were significantly more likely to have clinical depression than controls; patients tended to be more likely to present with anxiety and insomnia but these did not reach significance; significantly more female patients presented with depression whereas there was no significant difference between male patients and controls; 30-40% of both patients and controls reported worsening of motor performance and anxiety but there were no significant differences; females in both groups were more likely to report worsening of motor functioning and anxiety; multivariate regression showed that motor experiences of daily living was associated with depression and anxiety in patients; being male was a significant risk factor for patients' anxiety; univariate regression showed that motor experiences of daily living was associated with insomnia but this did not reach significance in the multivariate model; neither univariate or multivariate regression demonstrated significant risk factors for subjective worsening of motor performance, anxiety or insomnia. Kumar et al. (2020) 28 Approximately one fifth reported worsening of motor symptoms; 17.9% reported worsening forgetfulness; 11.5% reported worsening aggressive or impulsive behaviour; 20.2% reported worsening depressive symptoms; 21.5% reported worsening anxiety; 25.1% reported worsening easy fatiguability; 23.9% reported worsening sleep disturbances; sleep disturbances were more common in those lacking adequate support at home during home confinement; difficulty seeking formal neurology consultations was reported by 42.3% mostly due to lack of transportation but was not an independent predictor of symptomatic worsening; 7.5% reported medication unavailability; no significant change in duration of daily physical exercise but daily screen time significantly increased during home confinement; during home confinement 54.2% reported dissatisfaction with quality of life, with worsening of Parkinson's symptoms (38.5%) and fear of contracting COVID (19.5%) the most common reasons. Oppo et al. (2020) 21 Stress worsened during home confinement for 43.8% of patients and 53.1% of caregivers; patients experiencing increased stress had significantly higher anxiety and depression scores as well as non-motor symptoms scores; worsening of stress occurred significantly more in caregivers of patients with high non-motor symptoms scores; multivariate analysis showed worsening stress in caregivers was associated with patients' anxiety and depression and non-motor symptoms; higher caregiver strain was associated with patients' higher non-motor symptoms score; patients practising daily physical activity had significantly lower anxiety and depression scores than those who were inactive; there was a significant association between anxiety in patients and lack of physical activity even when controlling for age, disease duration, total levodopa equivalent daily dose, disease severity, non-motor symptoms and impulsive-compulsive symptoms. Palermo et al. (2020) 22 The majority of patients did not experience subjective worsening of Parkinson's symptoms, depression, or sleep but reported a subjective worsening of anxiety and cognitive symptoms, particularly memory and attention, independent of age, education and disease duration. Piano et al. (2020) 23 49% reported perception of global neurological worsening; 43% motor worsening; 28% psychiatric worsening; 87% discontinuation of outpatient neurological visits; 61% discontinuation of physiotherapy; 18% need for urgent outpatient neurological visit; 3% difficulties in finding medication; 14% difficulties in managing DBS device; 23% feelings of insecurity about DBS device; 30% problems with DBS device; 27% worsening of relationship with own body; 32% sleep disorders; 42% mood impairment; 41% depression; 12% panic attacks; 8% persecutory delusions; 13% visual hallucinations; 8% suicidal ideation; 20% impulsive-compulsive behaviours; no significant differences in motor or psychiatric symptoms in those with symptoms suggestive of COVID-19 and those without; significant correlation between motor worsening and discontinuation of physiotherapy; significant correlation between psychiatric worsening and chronic benzodiazepine use; significant correlation between motor and psychiatric worsening and need for urgent outpatient neurological visit, difficulties in management of DBS device, insecurity about DBS device, worsening of relationship with own body, sleep disorders, and depression; subgroup with worsening psychiatric symptoms scored significantly lower on the IADL. Prasad et al. (2020) 29 Only 8% of patients and 4% of caregivers perceived that patients were at high risk of contracting COVID; 4% of patients and 6% of caregivers reported patients were facing problems due to the pandemic; these problems included inability to consult a doctor, inability to procure free medication, and inability to go for walks; 11% of patients and 10% of caregivers perceived new or worsening symptoms in the patients; only one patient reported more anxiety or depression. Salari et al. (2020) 38 Severe anxiety recorded in 25.5% of patients and 4.8% of controls; 60% of caregivers had anxiety with 4.2% demonstrating severe anxiety; significant difference in anxiety levelshighest in patients, then caregivers, and lowest in controls; people with a higher education had more anxiety; no correlation between Parkinson's disease duration and anxiety severity; strong correlation between severity of anxiety in patients and fear of getting COVID-19 and this correlation was significantly higher than the controls; strong correlation between being infected by COVID-19 and anxiety in patients; higher anxiety in patients who were concerned about drug availability during lockdown as well as in those with comorbid chronic medical conditions. Santos-Garcia et al. (2020) 44 46% enquired about clinical services (e.g. confirmation of scheduled activities, required prescriptions, or the suspension of rehabilitation programmes such as physiotherapy); 28% communication about an acute clinical worsening(50% increase in motor disturbances, 25% augmented anxiety, 18% had developed/worsened neuropsychiatric symptoms, 16% complained about other non-motor symptoms such as fatigue or pain); 17% asked about the relationship between COVID-19 and PD; 8% informed about an intercurrent event; those who asked about relationships between COVID-19 and PD were significantly younger than those who enquired about clinical services; those who asked about relationships between COVID-19 and PD had significantly milder PD than those who informed about intercurrent events; suggests overall that PwPD need appropriate information, timely updates on changes in clinical services, and continuity of care during the pandemic. Schirinzi et al. (2020b) 25 Number of patients under physiotherapy/rehabilitation decreased from 43% to 9.7% during lockdown, a 78% reduction; total number of patients playing sports remained stable (53/59 continued, 7 started during lockdown); patients who did sport had a significantly shorter disease duration compared to inactive patients, whereas age, gender, age at onset, total symptom severity and depression did not differ; weekly physical activity was significantly higher during the pandemic in those who played sports than those who were inactive; no differences between technologybased tool users and non-users; 59.5% reported perception of worsening of global health; worsening patients did not differ by age, age at onset, gender or disease duration; those reporting worsening symptoms had significantly higher PWBM and depression scores and lower intensity of physical activity; intensity of physical activity was inversely associated with worsening symptoms, independently from age, age at onset, disease duration, depression, and PWBM scores; 86% based their training on known exercises; 63% used assistive technology-based tools; females were significantly more likely to use these. Shalash et al. (2020) 36 Most patients reported a negative impact on their mental health, physical activity, and health care; compared with controls, patients showed significantly worse stress, depression, anxiety, moderate physical activity, walking, total physical activity, and most of the PDQ39 dimensions; patients showed a significant decline in physical activity compared with pre-lockdown; depression and anxiety were positively correlated with prelockdown motor severity-off; post-lockdown depression was positively correlated with pre-lockdown depression and negatively with cognition; total physical activity was negatively correlated with depression, prelockdown depression and pre-lockdown motor severity-on but positively correlated with education and cognition; total PDQ39 scores were significantly correlated with depression, anxiety, stress, pre-lockdown motor severity, pre-lockdown depression, and patients' worry about unavailability of medication. Song et al. (2020) 43 Amount, duration and frequency of exercise all reduced during the pandemic; decrease in number of patients doing indoor-solo exercise; increase in patients who do not exercise; one third (33%) reported subjective worsening of both motor and non-motor features; most frequently reported aggravated motor symptoms were slowness and tremors while most frequently reported non-motor symptoms were stress, fatigue and increased aches and pains; activities of daily living significantly decreased during the pandemic but there was no difference in UPDRS part 3 score; 45% reported doing less exercise during the pandemic; reduced exercise group reported more motor and non-motor aggravation than the sustained exercise group; most common reasons for reduction in exercise volume were closing of sports facilities and concerns about contracting COVID-19 when going out for exercise; those in the reduced exercise group were those who had exercised significantly more pre-pandemic; no significant difference in age, gender, education level or disease duration between reduced and sustained exercise groups. Suzuki et al. 31 Health-related quality of life, physical function, role physical, general health, vitality and physical component summary scores were significantly worse in patients than caregivers; proportion of individuals with depression or anxiety did not differ between groups; patients had a significantly higher rate of comorbidities; same worsening trends according to the PGIC scale in both patients and caregivers; worsening of Parkinson's symptoms, stress and decreased physical activity seen in 29%, 37% and 44% of patients respectively; 16% reported problems with hospital access but none reported medication shortages; in patients, anxiety, stress, female gender, depression and longer disease duration predicted worse scores on the mental aspect of health-related quality of life; in caregivers, this was associated with depression, stress and worsening of patients' mood; in stepwise regression, anxiety, depression, stress and disease severity had negative effects on quality of life; in caregivers depression and anxiety had negative effects on quality of life. Templeton et al. 35 Participants reported feeling their best after exercise and when in a comfortable environment; patients reported minimal change in the number of active days per week, but the number of active minutes per day and the number of total activities showed a notable decrease due to COVID-19 restrictions; 82.14% reported at least one symptom changing moderately and 57.14% reported at least one symptom changing severely; 67.86% reported multiple symptoms changing moderately and 42.86% reported multiple symptoms changing severely; the most frequently reported symptoms that worsened were autonomic function, speech, and motor function; women indicated negative sleep changes. Thomsen et al. (2021) 46 Quality of life scores improved during the pandemic; participants reported significantly better health-related quality of life during the peak COVID-19 in spring 2020 compared with the pre-COVID period; significant improvements in concentration and difficulty getting around in public places, but close relationships and feeling depressed had worsened; freetext descriptions provided explanations for the improvement such as not having typical social pressures, enjoying life feeling simple and slow, and enjoying being at home; 59/67 experienced less sleep disturbance during the pandemic; in the free-text responses anxiety appeared to be associated with re-constructing normal life and adapting to new routines. Van der Heide et al. (2020) 41 Higher stressor load was associated with higher perceived stress and symptom severity; positive relationship between stressor load and increased disease severity was mediated by increased levels of perceived stress; 46.6% of patients were significantly less active than before the pandemic; patients with less physical activity experienced more worsening of disease symptoms; no relationship between time spent on physical activity and degree of perceived stress; patients with higher perceived stress experienced more worsening of disease symptoms; patients with more severe disease symptoms experienced more worsening of these symptoms during the pandemic (most frequently: rigidity, fatigue, tremor, pain and concentration); 93.1% reported loss of social contact as a stressor; 91.7% reported COVID-related media coverage as a stressor; 78.7% reported not being able to perform usual physical or leisure activities as a stressor; 75.6% reported feeling restricted to the home as a stressor; most burdensome to the patients were not being able to attend the funeral of a loved one, being restricted in visiting loved ones in hospital, loss of social contact and not being able to perform usual physical or leisure activities; people with higher perceived stress had lower scores on social support, trait resilience, optimism, positive appraisal style and higher anxiety, rumination and neuroticism; no association between stress and age, disease duration, gender, time of physical activity, cognitive abilities or behavioural coping style. Xia et al. (2020) 27 Patients had significantly poorer sleep quality, shorter sleep duration, higher rates of severe sleep dysfunction, worse daytime dysfunction and higher depression; over 60% of patients had sleep disturbances; sleep latency, sleep efficiency and use of sleep medication did not differ between groups; in patients, sleep dysfunction had a significant association with exacerbation of disease symptoms, anxiety, depression and inadequate medical consultation; females had significantly poorer sleep quality, shorter sleep duration, more severe daytime sleepiness and greater anxiety and depression; female patients were significantly more likely to follow news about the pandemic. Yule et al. 45 Prevalence of impulse control behaviours was higher during lockdown than pre-COVID; 31% showed an increase in impulsive-compulsive behaviours while 12% showed a decrease; participants reported varying levels of distress and control over behaviours; restrictions both reduced and increased opportunities for impulsive-compulsive behaviours such as compulsive shopping; participants described having more time to spend on hobbies and getting 'obsessed' with specific interests; state anxiety was significantly higher than trait anxiety indicating that anxiety increased during lockdown; trait impulsivity, state anxiety and apathy were all significant predictors of impulsive-compulsive behaviours during lockdown Zipprich et al. (2020) 37 Most patients reported being well or sufficiently informed about COVID-19; only 5.1% felt poorly informed; 5.1% felt they received too much information about the virus; 94.9% received information from television news and 47.5% actively sought additional information, mainly from the internet or via acquaintances in the medical profession; 94.9% saw the virus as dangerous; most common reason for this (in approximately one third of patients) was that they saw themselves as being at risk; 94.9% thought the current restrictions were necessary and sufficient; 61.6% had been recommended to stay at home more by their families; 72.7% reported they had changed their behaviour since the appearance of the virus; 4.0% reported no protective measures; the most common reported behaviours were staying at home, reducing social contact and wearing a mask; 86.9% had reduced contacts with relatives and friends; 73.7% had grandchildren, 83.6% of these did not have contact with their grandchildren and 73.6% of these stated they suffered from this; 58.6% reported anxieties and worries about the present situation; greatest fear was infection of coronavirus; general uncertainty, economic and social developments, and possible loss of medical care were also worries; physical burdens included lack of outdoor activities (10.1%), worsening of Parkinson's disease (19.2%) and further illness or injury; mental stresses included lack of social contacts and ability to go outside (22.2%), fear of becoming infected (10.1%) and other fears and worries (32.3%); 31.3% had a decrease in mobility since the beginning of restrictions; many prescribed therapies had been cancelled including 63.2% of physiotherapy, 57.5% of occupational therapy and 62.5% of speech therapy; more patients than controls had actively sought COVID information and more patients believed the virus was dangerous; females were significantly more likely to view the current situation as threatening. J o u r n a l P r e -p r o o f COVID-19 coronavirus pandemic The psychological impact of quarantine and how to reduce it: Rapid review of the evidence The Impact of the COVID-19 Pandemic on Parkinson's Disease: Hidden Sorrows and Emerging Opportunities Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium Strategies to mitigate impacts of the COVID-19 pandemic on patients treated with deep brain stimulation The Impact of COVID-19 on Access to Parkinson's Disease Medication Impact of the COVID-19 pandemic on parkinson's disease and movement disorders Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease Evaluation of quality of life and psychological aspects of Parkinson's disease patients who participate in a support group Synergy of pandemics-social isolation is associated with worsened Parkinson severity and quality of life We can work it out: Group decision-making builds social identity and enhances the cognitive performance of care residents Depression in neurological disorders: Parkinson's disease, multiple sclerosis, and stroke Parkinson's disease: A systematic review and meta-analysis Prevalence of Obsessive-Compulsive Symptoms in Elderly Parkinson Disease Patients: A Case-Control Study Scoping studies: towards a methodological framework Using thematic analysis in psychology Changes in Motor, Cognitive, and Behavioral Symptoms in Parkinson's Disease and Mild Cognitive Impairment During the COVID-19 Lockdown Correlates of Psychological Distress in Patients with Parkinson's Disease During the COVID-19 Outbreak Prevalence and impact of COVID-19 in Parkinson's disease: evidence from a multi-center survey in Tuscany region COVID-19 Pandemic and Psychiatric Symptoms: The Impact on Parkinson's Disease in the Elderly Parkinson's Disease Symptoms Have a Distinct Impact on Caregivers' and Patients' Stress: A Study Assessing the Consequences of the COVID-19 Lockdown Impact of Coronavirus Disease 2019 Pandemic on Cognition in Parkinson's Disease Effects of COVID-19 Lockdown on Movement Disorders Patients With Deep Brain Stimulation: A Multicenter Survey Self-reported needs of patients with Parkinson's disease during COVID-19 emergency in Italy Physical Activity Changes and Correlate Effects in Patients with Parkinson's Disease during COVID-19 Lockdown In uence of the COVID-19 pandemic on quality of life of patients with Parkinson's disease Investigation on sleep and mental health of patients with Parkinson's disease during the Coronavirus disease 2019 pandemic Impact of home confinement during COVID-19 pandemic on Parkinson's disease Parkinson's Disease and COVID-19: Perceptions and Implications in Patients and Caregivers Risk factors for neuropsychiatric symptoms in patients with Parkinson's disease during COVID-19 pandemic in Japan Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Parkinson's Disease and Their Caregivers: A Single-Center Survey in Tochigi Prefecture Impact of the COVID-19 pandemic on physical activity, anxiety, and depression in patients with Parkinson's disease. International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation Covid-19 perception and self reported impact of pandemic on Parkinson's disease symptoms of patients with physically independent Parkinson's disease The impact of COVID-19 and social distancing on people with Parkinson's disease: a survey study Negative Effects of COVID-19 Stayat-Home Mandates on Physical Intervention Outcomes: A Preliminary Study Mental Health, Physical Activity, and Quality of Life in Parkinson's Disease During COVID Knowledge, Attitudes, Practices, and Burden During the COVID-19 Pandemic in People with Parkinson's Disease in Germany Unmet Needs of People With Parkinson's Disease and Their Caregivers During COVID-19-Related Confinement: An Explorative Secondary Data Analysis No impact of confinement during COVID-19 pandemic on anxiety and depression in Parkinsonian patients Impact of Physiotherapy Absence in COVID-19 Pandemic on Neurological State of Patients With Parkinson Disease The changes of exercise pattern and clinical symptoms in patients with Parkinson's disease in the era of COVID-19 pandemic Impact of Coronavirus Disease 2019 Pandemic on Parkinson's Disease: A Cross-Sectional Survey of 568 Spanish Patients People with Parkinson's report increased impulse control behaviours during the COVID-19 UK lockdown. Parkinsonism and Related Disorders Life with Parkinson's Disease During the COVID-19 Pandemic: The Pressure Is "OFF The Effect of the COVID-19 Pandemic on People with Parkinson's Disease A scoping review of COVID-19 experiences of people living with dementia The experience of older people instructed to shield or self-isolate during the COVID-19 pandemic Attitudes toward telemedicine of patients with Parkinson's disease during the COVID-19 pandemic How COVID-19 will boost remote exercise-based treatment in Parkinson's disease: a narrative review Promoting Physical Activity via Telehealth in People With Parkinson Disease: The Path Forward After the COVID-19 Pandemic? A randomised controlled trial of a home based exercise programme to reduce the risk of falling among people with Parkinson's disease Management of neurorehabilitation during the covid-19 pandemic Unlocking the social cure Social Prescribing as 'Social Cure': A longitudinal study of the health benefits of social connectedness within a Social Prescribing pathway Social support and psychological outcome in people with Parkinson's disease: Evidence for a specific pattern of associations J o u r n a l P r e -p r o o f 72.7% remained active during confinement; 65.7% reported a worsening of symptoms (47.7% bradykinesia, 41.4% sleep problems, 40.7% rigidity, 34 33 68/86 were aware of being 'high risk'; 100% were washing hands often and 98.8% wearing a mask; 88.4% stayed completely at home whereas 11.6% visited relatives; 46.5% reported worsening bradykinesia; no correlation between bradykinesia and depression or anxiety; most common new or worsened non-motor symptoms were fatigue Competing interests: None declared.Ethical approval: Not required; no primary data collected.